I hope that you are doing well.
Starting on slide three, you will find a few highlights from the quarter.
We serve patients and consumers across a variety of end market.
And this makes after a resilient business through economic cycles.
In the most recent period is no exception.
We have the industry's widest range of dispensing systems, active material science solutions and drug delivery technologies and services that we leverage across our reporting segments.
Though sales grew modestly on the resin price adjustments.
In pharma the increased demand for our injectable components including supplying some of the COVID-19 vaccine distributions, and increased demand for our active material science solution, including those for COVID-19 test kits, offset declines in the prescription drug and consumer healthcare markets.
